|
BTBD3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.81559997539205E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.21259677246621E-11 |
| Normal-vs-Stage2 |
1.305780E-02 |
| Normal-vs-Stage3 |
5.423600E-03 |
| Normal-vs-Stage4 |
8.724800E-01 |
| Stage1-vs-Stage2 |
4.484200E-01 |
| Stage1-vs-Stage3 |
2.470400E-02 |
| Stage1-vs-Stage4 |
1.26209999995464E-06 |
| Stage2-vs-Stage3 |
4.266400E-01 |
| Stage2-vs-Stage4 |
2.737900E-02 |
| Stage3-vs-Stage4 |
3.291600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.13610051658497E-10 |
| Normal-vs-AfricanAmerican |
2.944600E-01 |
| Normal-vs-Asian |
6.140400E-01 |
| Caucasian-vs-AfricanAmerican |
6.358400E-02 |
| Caucasian-vs-Asian |
5.714000E-01 |
| AfricanAmerican-vs-Asian |
8.678000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.37900000032987E-07 |
| Normal-vs-Female |
2.29269999996173E-06 |
| Male-vs-Female |
7.376000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.027600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.21020000032735E-07 |
| Normal-vs-Age(61-80Yrs) |
9.04880000041075E-07 |
| Normal-vs-Age(81-100Yrs) |
5.039600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.677000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.506000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.083400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.372200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.660800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.989600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.335800E-03 |
| Normal-vs-Grade 2 |
3.28181926079196E-13 |
| Normal-vs-Grade 3 |
7.615400E-03 |
| Normal-vs-Grade 4 |
9.192000E-01 |
| Grade 1-vs-Grade 2 |
4.787900E-02 |
| Grade 1-vs-Grade 3 |
2.369600E-02 |
| Grade 1-vs-Grade 4 |
9.378200E-03 |
| Grade 2-vs-Grade 3 |
1.07530000004186E-06 |
| Grade 2-vs-Grade 4 |
3.30520000002554E-06 |
| Grade 3-vs-Grade 4 |
1.112760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
2.611900E-02 |
| ccA subtype-vs-ccB subtype |
2.74909999986583E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.75699999996437E-06 |
| Normal-vs-N1 |
7.402200E-01 |
| N0-vs-N1 |
3.528400E-01 |
|
|
